Latest news
Phase I Trial Evaluates Allogeneic CD70-Targeted CAR T-Cell Therapy in Advanced Renal Cell Carcinoma - The ASCO PostThe ASCO Post · Wed, 05 Aug 2026 14:32:11 GMTOblenio Doses First Patients in Phase 1a Trial of Trispecific T-Cell Engager LBL-051 - biopharminternational.combiopharminternational.com · Tue, 04 Aug 2026 17:05:26 GMTCREATE Medicines Receives Approval to Initiate First-in-Human Phase 1/2 Clinical Trial of In Vivo CAR-T Candidate CRT-402 for Autoimmune Diseases - PR NewswirePR Newswire · Thu, 30 Jul 2026 07:00:00 GMTIntellia: Phase 3 HAELO Win Doesn't Fix The Commercial Problem - Seeking AlphaSeeking Alpha · Wed, 29 Jul 2026 07:00:00 GMT